We also observed that the degranulation capacity of tumor‐infiltrating CD8 T cells was increased on mice intratumorally treated with anti‐NKG2A/Qa1b and/or NK cells when compared to isotype control‐treated mice (Appendix Fig S3A–C). Here, KLRC1 is linked to neoplasm.